Presentations

08:00

Subthreshold Inflammation Matters: A Continuum Model of TCMR Risk

Aravind Cherukuri (US)

Bio Abstract

08:10

Microvascular Inflammation(MVI) In The Crosshairs: Do Allo- or Autoantibodies Shape Kidney Allograft Pathology?

Vamsee Chirumamilla (US)

Bio Abstract

08:20

Augmented washed microbiota transplantation for chronic allograft fibrosis in renal transplantation

Hongdi Cao (CN)

Bio Abstract

08:30

Clinical outcomes of the use of subcutaneous daratumumab for donor-derived cell-free DNA guided treatment of antibody mediated rejection in asian kidney transplant recipients at the Singapore General Hospital

Sobhana Thangaraju (SG)

Bio Abstract

08:37

Upregulation of cell death pathways in kidney rejection

Xinyi Ding (AU)

Bio Abstract

08:42

Kidney allograft outcomes in acute T cell-mediated rejection accompanied by microvascular inflammation: An inverse probability weighted multicentre cohort study

Jiayue Wang (AU)

Bio Abstract

08:47

Molecular Diagnosis of kidney allograft rejection using the BHOT gene panel-based HistoMx System in Chinese population: a validation study

Longshan Liu (CN)

Bio Abstract